Afib triggered by a cell that resembles a pigment-producing skin cellOctober 13, 2009The source and mechanisms underlying the abnormal heart beats that initiate atrial fibrillation (Afib), the most common type of abnormal heart beat, have not been well determined. However, a group of researchers at the University of Pennsylvania, Philadelphia, has now identified a population of cells that are like pigment producing cells in the skin (melanocytes) in the atria of the heart and pulmonary veins of mice and humans and uncovered evidence in mice that these cells contribute to Afib. Initial analysis by the group, led by Vickas Patel and Jonathan Epstein, identified a population of cells in the atrium and pulmonary veins of mice and humans that expressed the protein DCT, which is involved in making the skin pigment melanin. Further work showed that Dct-expressing cells in the mouse heart were distinct from both heart muscle cells and skin melanocytes, although they could conduct electrical currents, which are important for coordinated contraction of the heart. Adult mice lacking Dct were susceptible to induced and spontaneous Afib and the melanocyte-like cells in their heart exhibited abnormal conduction of electrical currents in vitro. As mice lacking both melanocyte-like cells in the heart and Dct failed to develop either induced or spontaneous Afib, the authors suggest that dysfunctional melanocyte-like cells in the heart may be a trigger of Afib in humans. Journal of Clinical Investigation |
|||||||||||||||||||||
| Related Melanocytes Current Events and Melanocytes News Articles New findings on the formation of body pigment The skin's pigment cells can be formed from completely different cells than has hitherto been thought, a new study from the Swedish medical university Karolinska Institutet shows. The results, which are published in the journal Cell, also mean the discovery of a new kind of stem cell. Novel epigenetic markers of melanoma may herald new treatments for patients Melanoma is the most serious form of skin cancer, diagnosed in more than 50,000 new patients in the United States annually. While the rate of incidences continues to rise, survival rate has not improved and the race is on to find the genetic and cellular changes driving melanoma and to devise new means of detection and treatment. Zebrafish provide a model for cancerous melanoma in humans In a new study published in Disease Models & Mechanisms, scientists use the zebrafish to gain insight into the influence of known cancer genes on the development and progression of melanoma, an aggressive form of human skin cancer with limited treatment options. Scientists create mouse model of melanoma that generates hope for the use of targeted therapies Researchers have developed a new mouse model that allows them to replicate normal pigment cells at the earliest stages of conversion to malignant skin cancer in humans. UBC researchers discover gene mutation that causes eye cancer A University of British Columbia geneticist has discovered a gene mutation that can cause the most common eye cancer - uveal melanoma. NYU researchers demonstrate activity of mebendazole in metastatic melanoma Researchers at the NYU Cancer Institute and the Ronald O. Perelman Department of Dermatology have identified mebendazole, a drug used globally to treat parasitic infections, as a novel investigational agent for the treatment of chemotherapy-resistant malignant melanoma. Research Suggests New Options in Treating Skin Pigment Problems Melanocytes are not the only cells responsible for differences in skin coloration. New research from the University of Cincinnati (UC) has shown that some of the most basic cells on the skin's surface influence pigment production and help regulate skin coloration. Scientists Implicate Gene in Vitiligo and Other Autoimmune Diseases In a study appearing in the March 22 New England Journal of Medicine, scientists supported by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) have discovered a connection between a specific gene and the inflammatory skin condition vitiligo, as well as a possible host of autoimmune diseases. 'Guardian of the genome' protein found to underlie skin tanning A protein known as the "master watchman of the genome" for its ability to guard against cancer-causing DNA damage has been found to provide an entirely different level of cancer protection: By prompting the skin to tan in response to ultraviolet light from the sun, it deters the development of melanoma skin cancer, the fastest-increasing form of cancer in the world. Why don't all moles progress to melanoma? Everyone has moles. Most of the time, they are nothing but a cosmetic nuisance. But sometimes pigment-producing cells in moles called melanocytes start dividing abnormally to form a deadly form of skin cancer called melanoma. More Melanocytes Current Events and Melanocytes News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||